Normal and Pathologic Soft Tissue Remodeling: Role of the Myofibroblast, with Special Emphasis on Liver and Kidney Fibrosis

Laboratory Investigation

Volumn 83, Issue 12, 2003, Pages 1689-1707

  Desmoulière, Alexis ^a   Darby, Ian A ^b   Gabbiani, Giulio ^c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b RMIT UNIVERSITY   (Australia)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT;

APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL KINETICS; CYTOKINE PRODUCTION; DISEASE MARKER; EXTRACELLULAR MATRIX; FIBROGENESIS; GRANULATION TISSUE; HEMOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNERVATION; KIDNEY FIBROSIS; LIVER FIBROSIS; MODULATION; MOLECULAR INTERACTION; MUSCLE FIBER CONTRACTION; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; SHORT SURVEY; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; FIBROBLASTS; FIBROSIS; GRANULATION TISSUE; HUMANS; KIDNEY; LIVER CIRRHOSIS;

EID: 0347364750     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000101911.53973.90     Document Type: Short Survey

References (179)

1. Abe R, Donnelly SC, Peng T, Bucala R, and Metz CN (2001). Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 166:7556-7562.
2. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, and Imai E (1996). Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155.
3. Akasawa Y, Fujita K, Ishikawa Y, Asuwa N, Inuzuka K, Ishihara M, Ito M, Masuda T, Akishima Y, Zhang L, Ito K, and Ishii T (2001). Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars and normal healed flat scars, and dermatofibroma. Wound Rep Reg 9:501-506.
4. Andrade ZA, Guerret S, and Fernandes AL (1999). Myofibroblasts in schistosomal portal fibrosis of man. Mam Inst Oswaldo Cruz 94:87-93.
5. Andreutti D, Gabbiani G, and Neuville P (1998). Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis. Lab Invest 78:1493-1502.
6. Arora PD and McCulloch CA (1994). Dependence of collagen remodelling on alpha-smooth muscle actin expression by fibroblasts. J Cell Physiol 159:161-175.
7. Athari A, Hanecke K, and Jungermann K (1994). Prostaglandin F2 alpha and D2 release from primary Ito cell cultures after stimulation with noradrenaline and ATP but not adenosine. Hepatology 20:142-148.
8. Badid C, Vincent M, McGregor B, Melin M, Hadj-Aissa A, Veysseyre C, Hartmann DJ, Desmoulière A, and Laville M (2000). Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 58:51-61.
9. Ballardini G, Groff P, Badiali de Giorgi L, Schuppan D, and Bianchi FB (1994). Ito cell heterogeneity: Desmin-negative Ito cells in normal rat liver. Hepatology 19:440-446.
10. Bascom CC, Wolfshohl JR, Coffey RJ Jr, Madisen L, Webb NR, Purchio AR, Derynck R, and Moses HL (1989). Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol 9:5508-5515.
11. Basson M and Burney R (1982). Defective wound healing in patients with paraplegia and quadriplegia. Surg Gynecol Obstr 155:9-12.
12. Beer HD, Gassmann MG, Munz B, Steiling H, Engelhardt F, Bleuel K, and Werner S (2000), Expression and function of keratinocyte growth factor and activin in skin morphogenesis and cutaneous wound repair. J Investig Dermatol Symp Proc 5:34-39.
13. Beno DW, Espinal R, Edelstein BM, and Davis BH (1993). Administration of prostaglandin E1 analog reduces rat hepatic and Ito cell collagen gene expression and collagen accumulation after bile duct ligation injury. Hepatology 17: 707-714.
14. Bhunchet E and Wake K (1992). Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis. Hepatology 16:1452-1473.
15. Bioulac-Sage P, Blanc JF, Lepreux S, Balabaud C, Rosenbaum J, and Desmoulière A (2000). Cirrhosis: Forever? Gastroenterol Clin Biol 24:877-882.
16. Bioulac-Sage P, Lafon ME, Le Bail B, and Balabaud C (1988). Perisinusoidal and pit cells in liver sinusoids. In: Bioulac-Sage P, and Balabaud C, editors. Sinusoids in human liver: Health and disease. Leiden: Kupffer Cell Foundation, 38-50.
17. Bioulac-Sage P, Lafon ME, Saric J, and Balabaud C (1990). Nerves and perisinusoidal cells in human liver. J Hepatol 10:105-112.
18. Birns M, Masek B, and Auerbach O (1962). The effects of experimental acute biliary obstruction and release on the rat liver. A histochemical study. Am J Pathol 40:95-112.
19. Blomhoff R and Wake K (1991). Perisinusoidal stellate cells of the liver: Important roles in retinol metabolism and fibrosis. FASEB J 5:271-277.
20. Bogatkevich GS, Tourkina E, Abrams CS, Harley RA, Silver RM, Ludwicka-Bradley A (2003). Contractile activity and smooth muscle-actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol 285:L334-L343.
21. Bogatkevich GS, Tourkina E, Silver RM, and Ludwicka-Bradley A (2001). Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem 276:45184-45192.
22. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, and Schuppan D (1997). Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 26:643-649.
23. Border WA and Ruoslahti E (1992). Transforming growth factor-beta in disease: The dark side of tissue repair. J Clin Invest 90:1-7.
24. Bork P (1993). The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327:125-130.
25. Brown LF, Dubin D, Lavigne L, Logan B, Dvorak HF, and Van De Water L (1993). Macrophages and fibroblasts express embryogenic fibronectins during cutaneous wound healing. Am J Pathol 142:793-801.
26. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, and van de Water L (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176: 1375-1379.
27. Buckingham ME, Alonso S, Barton P, Bugaisky G, Cohen A, Daubas P, Garner I, Minty A, Robert B, and Weydert A (1984). Actin and myosin genes, and their expression during myogenesis in the mouse. In: Davidson EH, and Firtel RA, editors. Molecular biology of development. New York: Liss AR, 275-292.
28. Cameron GR and Prasad LBM (1960). Recovery from biliary obstruction after spontaneous restoration of the obstructed common bile-duct. J Path Bact 80:127-136.
29. Cass DL, Sylvester KG, Yang EY, Crombleholme TM, and Adzick NS (1997). Myofibroblast persistence in fetal sheep wounds is associated with scar formation. J Pediatr Surg 32:1017-1021.
30. Cassiman D and Roskams T (2002). Beauty is in the eye of the beholder: Emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol 37:527-535.
31. Cassiman D, Libbrecht L, Desmet V, Denef C, and Roskams T (2002). Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 36:200-209.
32. Cassiman D, Roskams T, van Pelt J, Libbrecht L, Aertsen P, Crabbe T, Vankelecom H, and Denef C (2001). Alpha B-crystallin expression in human and rat hepatic stellate cells. J Hepatol 35:200-207.
33. Chiquet M, Renedo AS, Huber F, and Fluck M (2003). How do fibroblasts translate mechanical signals into changes in extracellular matrix production? Matrix Biol 22:73-80.
34. Cho JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn EG, Riecken EO, and Schuppan D (2000). An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 118: 1169-1178.
35. Chodon T, Sugihara T, Igawa HH, Funayama E, and Furukawa H (2000). Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-β1 can abrogate this resistance. Am J Pathol 157:1661-1669.
36. Christen T, Verin V, Bochaton-Piallat M, Popowski Y, Ramaekers F, Debruyne P, Camenzind E, van Eys G, and Gabbiani G (2001). Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation 103: 882-888.
37. Clark LD, Clark RK, and Heber-Katz E (1998). A new murine model for mammalian wound repair and regeneration. Clin Immunol Immunopathol 88:35-45.
38. Costa AMA, Tuchweber B, Lamireau T, Yousef IM, Balabaud C, Rosenbaum J, and Desmoulière A (2003). Role of apoptosis in the remodeling of cholestatic liver injury following release of the mechanical stress. Virchows Arch 442:372-380.
39. Costa AMA, Tuchweber B, Rubbia-Brandt L, Peyrol S, Chevallier M, Adham M, Gabbiani G, Rosenbaum J, and Desmoulière A (2001). Early activation of hepatic stellate cells and perisinusoidal extracellular matrix changes during ex vivo pig liver perfusion. J Submicrosc Cytol Pathol 33:321-340.
40. Darby I, Skalli O, and Gabbiani G (1990). Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63:21-29.
41. Darby IA, Bisucci T, Hewitson TD, and MacLellan DG (1997). Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol 29:191-200.
42. Darby IA, Bisucci T, Pittet B, Garbin S, Gabbiani G, and Desmoulière A (2002). Skin flap induced regression of granulation tissue correlates with reduced growth factor and increased metalloproteinase expression. J Pathol 197:117-127.
43. Desmoulière A and Gabbiani G (1996). The role of the myofibroblast in wound healing and fibrocontractive diseases. In: Clark RAF, editor. The Molecular and Cellular Biology of Wound Repair, 2nd ed. New York: Plenum Press Corporation, 391-423.
44. Desmoulière A, Badid C, Bochaton-Piallat ML, and Gabbiani G (1997a). Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol 29:19-30.
45. Desmoulière A, Darby I, Monte Alto Costa A, Raccurt M, Tuchweber B, Sommer P, and Gabbiani G (1997b). Extracellular matrix deposition, lysyl oxydase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest 76:765-778.
46. Desmoulière A, Geinoz A, Gabbiani F, and Gabbiani G (1993). Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-111.
47. Desmoulière A, Redard M, Darby I, and Gabbiani G (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56-66.
48. Desmoulière A, Rubbia-Brandt L, Abdiu A, Walz T, Macieira-Coelho A, and Gabbiani G (1992a). α-Smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by γ-interferon. Exp Cell Res 201: 64-73.
49. Desmoulière A, Rubbia-Brandt L, Grau G, and Gabbiani G (1992b). Heparin induces α-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. Lab Invest 67:716-726.
50. Desmoulière A, Xu G, Costa AMA, Yousef IM, Gabbiani G, and Tuchweber B (1999). Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells. J Hepatol 30:621-631.
51. Dranoff JA, Kruglov EA, Robson SC, Braun N, Zimmermann H, and Sevigny J (2002). The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver. Hepatology 36:1135-1144.
52. Dubuisson L, Desmoulière A, Decourt B, Ecade L, Bedin C, Boussarie L, Barrier L, Vidaud M, and Rosenbaum J (2002). Inhibition of liver fibrogenesis through noradrenergic antagonism. Hepatology 35:325-331.
53. Dubuisson L, Monvoisin A, Nielsen BS, Le Bail B, Bioulac-Sage P, and Rosenbaum J (2000). Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma. J Pathol 190:190-195.
54. Dugina V, Fontao L, Chaponnier C, Vasiliev J, and Gabbiani G (2001). Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci 114:3285-3296.
55. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, and Grotendorst GR (1999). Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: Down-regulation by cAMP. FASEB J 13:1774-1786.
56. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, and Gabbiani G (1994). Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105-113.
57. Estes JM, Vande Berg JS, Adzick NS, MacGillivray TE, Desmouliere A, and Gabbiani G (1994). Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 56:173-181.
58. Eyden BP (1993). Brief review of the fibronexus and its significance for myofibroblastic differentiation and tumor diagnosis. Ultrastruct Pathol 17:611-622.
59. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, and Lan HY (1999). Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro Kidney Int 56:1455-1467.
60. Faouzi S, Le Bail B, Neaud V, Boussarie L, Saric J, Bioulac-Sage P, Balabaud C, and Rosenbaum J (1999). Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: An in vivo and in vitro study. J Hepatol 30:275-284.
61. Fern RJ, Yesko CM, Thornhill BA, Kim HS, Smithies O, and Chevalier RL (1999). Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103:39-46.
62. Folger PA, Zekaria D, Grotendorst G, and Masur SK (2001). Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. Invest Ophthalmol Vis Sci 42:2534-2541.
63. Frazier K, Williams S, Kothapalli D, Klapper H, and Grotendorst GR (1996). Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107:404-411.
64. Frazier KS, Paredes A, Dube P, and Styer E (2000). Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation. Vet Pathol 37:328-335.
65. th ed. Philadelphia: Lippincott-Raven, 371-386.
66. Futakuchi M, Hirose M, Ogiso T, Kato K, Sano M, Ogawa K, and Shirai T (1999). Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model. Jpn J Cancer Res 90:1196-1202.
67. Gabbiani G (1998). Evolution and clinical implications of the myofibroblast concept. Cardiovasc Res 38:545-548.
68. Gabbiani G, Ryan GB, and Majno G (1971). Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27:549-550.
69. Glaser S, LeSage G, Alvaro D, Chowdury U, Kanno N, Francis H, Eisel W, and Alpini G (1999). Ablation of the D2 dopaminergic innervation by intraportal injection of 6-hydroxydopamine (6-OHDA) reduces cholangiocyte proliferative and secretory activity in bile duct ligated (BDL) rats (Abstract). Hepatology 30:A1088.
70. Godichaud S, Krisa S, Couronné B, Dubuisson L, Mérillon JM, Desmoulière A, and Rosenbaum J (2000). Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapewine-derived polyphenol. Hepatology 31:922-931.
71. Goldschmeding R, Aten J, Ito Y, Blom I, Rabelink T, and Weening JJ (2000). Connective tissue growth factor: Just another factor in renal fibrosis? Nephrol Dial Transplant 15:296-299.
72. Grillo HC (1963). Origin of fibroblasts in wound healing: An autoradiographic study of inhibition of cellular proliferation by local x-irradiation. Ann Surg 157:453-467.
73. Grinnell F (1994). Fibroblasts, myofibroblasts and wound contraction. J Cell Biol 124:401-404.
74. Grinnell F (2000). Fibroblast-collagen-matrix contraction: Growth-factor signalling and mechanical loading. Trends Cell Biol 10:362-365.
75. Grinnell F (2003). Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13:264-269.
76. Grinnell F, Ho CH, Tamariz E, Lee DJ, and Skuta G (2003). Dendritic fibroblasts in three-dimensional collagen matrices. Mol Biol Cell 14:384-395.
77. Grinnell F, Zhu M, Carlson MA, and Abrams JM (1999). Release of the mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res 248:608-619.
78. Guerret S, Desmoulière A, Chossegros P, Costa AMA, Badid C, Trépo C, Grimaud JA, and Chevallier M (1999). Long-term administration of interferon-α in non-responder patients with chronic hepatitis C: Follow-up over 5 years of liver fibrosis. J Viral Hepatitis 6:125-133.
79. Gupta S, Clarkson MR, Duggan J, and Brady HR (2000). Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58:1389-1399.
80. Hall A (1998). Rho GTPases and the actin cytoskeleton. Science 279:509-514.
81. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Flejou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, and Levy P (2001). Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344:418-423.
82. Hewitson TD and Becker GJ (1995). Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 15:111-117.
83. Hewitson TD, Martic M, Kelynack KJ, Pedagogos E, and Becker GJ (2000). Pentoxifylline reduces in vitro renal myofibroblast proliferation and collagen secretion. Am J Nephrol 20:82-88.
84. Higton DIR and James DW (1964). The force of contraction of full-thickness wounds of rabbit skin. Br J Surg 51:462-466.
85. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, and Chaponnier C (2001a). α-Smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12:2730-2741.
86. Hinz B, Dugina V, Ballestrem C, Wehrle-Haller B, and Chaponnier C (2003). Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell 14:2508-2519.
87. Hinz B, Gabbiani G, and Chaponnier C (2002). The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol 157:657-663.
88. Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, and Gabbiani G (2001 b). Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 159:1009-1020.
89. Horvath LZ, Friess H, Schilling M, Borisch B, Deflorin J, Gold LI, Korc M, and Buchler MW (1996). Altered expression of transforming growth factor-βs in chronic renal rejection. Kidney Int 50:489-498.
90. Howell DC, Goldsack NR, Marshall RP, McAnulty RJ, Starke R, Purdy G, Laurent GJ, and Chambers RC (2001). Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 159:1383-1395.
91. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, and Arthur MJ (1998). Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102:538-549.
92. Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, and Hori M (2000). Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58:1885-1892.
93. Ishidoya S, Morrisey J, McCracken R, Reyes A, and Klahr S (1995). Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294.
94. Ishihara H, Yoshimoto H, Fujioka M, Murakami R, Hirano A, Fujii T, Ohtsuru A, Namba H, and Yamashita S (2000). Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. J Invest Dermatol 115:1065-1071.
95. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, and Neilson EG (2002). Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350.
96. Jancso N, Jancso-Gabor A, and Szolcsanyl J (1967). Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 51:138-151.
97. Johnson P and Doll S (1984). Dermal nerves in human diabetic subjects. Diabetes 33:244-250.
98. Juliano RL and Haskill S (1993). Signal transduction from the extracellular matrix. J Cell Biol 120:577-585.
99. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, Pieczek A, Iwaguro H, Hayashi S-I, Isner JM, and Asahara T (2000). Vascular endothelial growth factor 165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86:1198-1202.
100. Kim LR, Whelpdale K, Zurowski M, and Pomeranz B (1998). Sympathetic denervation impairs epidermal healing in cutaneous wounds. Wound Rep Reg 6:194-201.
101. Kinnman N, Francoz C, Barbu V, Wendum D, Rey C, Hultcrantz R, Poupon R, and Housset C (2003). The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 83:163-173.
102. Kishimoto S (1984). The regeneration of substance-P containing nerve fibers in the process of burn wound healing in the guinea pig skin. J Invest Dermatol 83:219-223.
103. Klahr S, Ishidoya S, and Morrisey J (1995). Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 26:141-146.
104. Knittel T, Kobold D, Piscaglia F, Saile B, Neubauer K, Mehde M, Timpl R, and Ramadori G (1999a). Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: Distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol 112:387-401.
105. Knittel T, Kobold D, Saile B, Grundmann A, Neubauer K, Piscaglia F, and Ramadori G (1999b). Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117:1205-1221.
106. Kotani I, Sato A, Hayakawa H, Urano T, Takada Y, and Takada A (1995). Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res 77:493-504.
107. Kothapalli D, Frazier KS, Welply A, Segarini PR, and Grotendorst GR (1997). Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ 8:61-68.
108. Le Bail B, Faouzi S, Boussarie L, Guirouilh J, Blanc JF, Carles J, Bioulac-Sage P, Balabaud C, and Rosenbaum J (1999). Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol 189:46-52.
109. Leferovich JM and Heber-Katz E (2002). The scarless heart. Semin Cell Dev Biol 13:327-333.
110. LeSage G, Alvaro D, Benedetti A, Glaser S, Marucci L, Baiocchi L, Eisel W, Caligiuri A, Phinizy JL, Rodgers R, Francis H, and Alpini G (1999). Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. Gastroenterology 117:191-199.
111. Lieberthal W, Koh JS, and Levine JS (1998). Necrosis and apoptosis in acute renal failure. Semin Nephrol 18:505-518.
112. Liu M, Warn JD, Fan Q, and Smith PG (1999). Relationship between nerves and myofibroblasts during cutaneous wound healing in the developing rat. Cell Tissue Res 297:423-433.
113. Loukianov E, Loukianova T, and Periasamy M (1997). Myosin heavy chain isoforms in smooth muscle. Comp Biochem Physiol B Biochem Mol Biol 117:13-18.
114. Luo S, Benathan M, Raffoul W, Panizzon RG, and Egloff DV (2001). Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstructive Surg 107:87-96.
115. MacDonald RA (1959). Origin of fibroblasts in experimental healing wounds: Autoradiographic studies using tritiated thymidine. Surgery 46:376-382.
116. Machesky LM and Hall A (1996). Rho: A connection between membrane receptor signalling and the cytoskeleton. Trends Cell Biol 6:304-310.
117. Machesney M, Tidman N, Waseem A, Kirby L, and Leigh I (1998). Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol 152:1133-1141.
118. Maggi CA (1997). The effects of tachykinins on inflammatory and immune cells. Regul Pept 70:75-90.
119. Majno G, Gabbinai G, Hirschel BJ, Ryan GB, and Statkov PR (1971). Contraction of granulation tissue in vitro: Similarity to smooth muscle. Science 173:548-550.
120. Mallat A, Preaux AM, Blazejewski S, Rosenbaum J, Dhumeaux D, and Mavier P (1995). Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21:1003-1010.
121. Mallat A, Préaux AM, Serradeil-Le Gal C, Raufaste D, Gallois C, Brenner DA, Bradham C, Maclouf J, Iourgenko V, Fouassier L, Dhumeaux D, Mavier P, and Lotersztajn S (1996). Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors. J Clin Invest 98:2771-2778.
122. Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trépo C, and Grimaud JA (1993). Interferon-α2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation. Hepatology 18:1344-1349.
123. Molitoris BA (1997). Putting the actin cytoskeleton into perspective: Pathophysiology of ischemic alterations. Am J Physiol 272:F430-F433.
124. Monvoisin A, Bisson C, Si-Tayeb K, Balabaud C, Desmoulière A, and Rosenbaum J (2002). Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer 97:157-162.
125. Monvoisin A, Neaud V, De Lédinghen V, Dubuisson L, Balabaud C, Bioulac-Sage P, Desmoulière A, and Rosenbaum J (1999). Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J Hepatol 30:511-518.
126. Moulin V, Tam BY, Castilloux G, Auger FA, O'Connor-McCourt MI, Philip A, and Germain L (2001). Fetal and adult human skin fibroblasts display intrinsic differences in contractile capacity. J Cell Physiol 188:211-220.
127. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, and Iredale JP (2002). Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: Implications for reversibility of liver fibrosis. J Biol Chem 277:11069-11076.
128. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, and Rosenbaum J (1997). Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor. Hepatology 26:1458-1466.
129. Neaud V, Hisaka T, Monvoisin A, Bedin C, Balabaud C, Foster DC, Desmouliere A, Kisiel W, and Rosenbaum J (2000). Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 275:35565-35569.
130. Nilsson J, Euler AM, and Dalsgaard CJ (1986). Stimulation of connective tissue cell growth by substance P and substance K. Nature 315:61-63.
131. Okada H, Inoue T, Kanno Y, Kobayashi T, Watanabe Y, Kopp JB, Carey RM, and Suzuki H (2002). Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney. Am J Pathol 160:765-772.
132. Okada H, Strutz F, Danoff T, and Neilson EG (1996). Possible pathogenesis in renal fibrosis. Kidney Int 49:S37-S39.
133. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins T, Jerums G, and Cooper ME (2001). Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108: 1853-1863.
134. Olivari N, Schrudde J, and Wahle H (1972). The surgical treatment of bedsores in paraplegics. Plast Reconst Surg 50:477-482.
135. Pan D, Zhe X, Jakkaraju S, Taylor GA, and Schuger L (2002). P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype. J Clin Invest 110:1349-1358.
136. Papatheodoridis GV, Papakonstantinou E, Andrioti E, Cholongitas E, Petraki K, Kontopoulou I, and Hadziyannis SJ (2003). Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 52:404-409.
137. Peters H, Noble NA, and Border WA (1997). Transforming growth factor-beta in human glomerular injury. Curr Opin Nephrol Hypertens 6:389-393.
138. Peterson TC (1993). Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology 17:486-493.
139. Pinzani M (1995). Hepatic stellate (ITO) cells: Expanding roles for a liver-specific pericyte. J Hepatol 22:700-706.
140. Pittet B, Rubbia-Brandt L, Desmoulière A, Sappino AP, Roggero P, Guerret S, Grimaud JA, Lacher R, Montandon D, and Gabbiani G (1994). Action of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: An open pilot study. Plast Reconstr Surg 93:1224-1235.
141. Raats JMH and Bloemendal H (1992). The role of protein domains in the assembly process of intermediate filaments. Progr Nucleic Acid Res Mol Biol 43:67-86.
142. Raetsch C, Jia JD, Boigk G, Bauer M, Hahn EG, Riecken EO, and Schuppan D (2002). Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut 50:241-247.
143. Razzaque MS and Taguchi T (2002). Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc 35:68-80.
144. Ronnov-Jessen L and Petersen OW (1993). Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68:696-707.
145. Ross R, Everett NB, and Tyler R (1970). Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J Cell Biol 44:645-654.
146. Rubbia-Brandt L, Mentha G, Desmoulière A, Costa AMA, Giostra E, Molas G, Enzan H, and Gabbiani G (1997). Hepatic stellate cells reversibly express α-smooth muscle actin during acute hepatic ischemia. Transplant Proc 29:2390-2395.
147. Rubbia-Brandt L, Sappino AP, and Gabbiani G (1991). Locally applied GM-CSF induces the accumulation of α-smooth muscle actin containing myofibroblasts. Virchows Arch [B] Cell Pathol 60:73-82.
148. Rubin E, Hutterer F, and Popper H (1968). Experimental hepatic fibrosis without hepatocellular regeneration. Am J Pathol 52:111-119.
149. Ruiz-Ortega M and Egido J (1997). Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 52:1497-1510.
150. Sappino SP, Schürch W, and Gabbiani G (1990). Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63:144-161.
151. Sedlaczek N, Jia JD, Bauer M, Herbst H, Ruehl M, Hahn EG, and Schuppan D (2001). Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 158:1239-1244.
152. Schiaffino S and Reggiani C (1996). Molecular diversity of myofibrillar proteins: Gene regulation and functional significance. Physiol Rev 76:371-423.
153. Schmitt-Gräff A, Desmoulière A, and Gabbiani G (1994). Heterogeneity of myofibroblast phenotypic features: An example of fibroblastic cell plasticity. Virchows Arch 425:3-24.
154. Schürch W, Seemayer T, and Gabbiani G (1998). The myofibroblast. A quarter century after its discovery. Am J Surg Pathol 22:141-147.
155. Serini G and Gabbiani G (1999). Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 250:273-283.
156. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, and Gabbiani G (1998). The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142:873-881.
157. Shao R, Shi Z, Gotwals PJ, Koteliansky VE, George J, and Rockey DC (2003). Cell and molecular regulation of endothelin-1 production during hepatic wound healing. Mol Biol Cell 14:2327-2341.
158. Singer II, Kawka DW, Kazazis DM, and Clark RAF (1984). In vivo codistribution of fibronectin and actin fibers in granulation tissue: Immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol 98:2091-2106.
159. Slott PA, Liu MH, and Tavoloni N (1990). Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 99:466-477.
160. Song IS, Bunnett NW, Olerud JE, Harten B, Steinhoff M, Brown JR, Sung KJ, Armstrong CA, and Ansel JC (2000). Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R). Exp Dermatol 9:42-52.
161. Stickel F, Brinkhaus B, Krahmer N, Seitz HK, Hahn EG, and Schuppan D (2002). Antifibrotic properties of botanicals in chronic liver disease. Hepatogastroenterology 49:1102-1108.
162. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, and Neilson EG (1995). Identification and characterization of a fibroblast marker FSP1. J Cell Biol 130:393-405.
163. Sztark F (1986). Perisinusoidal cells in patients with normal liver histology. A morphological study. J Hepatol 2:358-369.
164. Teofoli P, Barduagni S, Ribuffo M, Campanella A, De Pita O, and Puddu P (1999). Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatologocial Sci 22:31-37.
165. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, and Brown RA (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3:349-363.
166. Tuchweber B, Desmoulière A, Bochaton-Piallat ML, Rubbia-Brandt L, and Gabbiani G (1996). Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 74:265-278.
167. Uchio K, Tuchweber B, Manabe N, Gabbiani G, Rosenbaum J, and Desmoulière A (2002). Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts. Lab Invest 82:619-628.
168. Ueno T and Tanikawa K (1997). Intralobular innervation and lipocyte contractility in the liver. Nutrition 13:141-148.
169. Van der Loop FT, Gabbiani G, Kohnen G, Ramaekers FC, and van Eys GJ (1997). Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol 17:665-671.
170. Van der Loop FT, Schaart G, Timmer ED, Ramaekers FC, and van Eys GJ (1996). Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 134:401-411.
171. Vandekerckhove J and Weber K (1978). Mammalian cytoplasmic actins are the products of at least two genes and differ in primary structure in at least 25 identified positions from skeletal muscle actins. Proc Natl Acad Sci USA 75: 1106-1110.
172. Vyalov S, Desmoulière A, and Gabbiani G (1993). GM-CSF-induced granulation tissue formation: Relationships between macrophage and myofibroblast accumulation. Virchows Arch [B] Cell Pathol 63:231-239.
173. Wallengren J (1997). Vasoactive peptides in the skin. J Invest Dermatol Symp Proc 2:49-55.
174. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, and Williams LT (1992). Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 89:6896-6900.
175. Wysocki AB, Staiano-Coico L, and Grinnell F (1993). Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64-68.
176. Xu G, Redard M, Gabbiani G, and Neuville P (1997). Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am J Pathol 151:1741-1749.
177. Yamada KM and Clark RAF (1996). Provisional matrix. In: Clark RAF, editor. The molecular and cellular biology of wound repair, 2nd ed. New York: Plenum Press Corporation, 51-93.
178. Zhang K, Rekhter MD, Gordon D, and Phan SH (1994). Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 145: 114-125.
179. Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, and Maggi CA (1990). Substance P stimulates neovascularization in vivo and proliferation of cultures epithelial cells. Microvasc Res 40:264-278.